3 Cryogenic Tanks Maker, Bimetal Strips Maker and Pathology and Diagnostics Company Stocks With a Strong Future Roadmap: Inox India, Shivalik Bimetal and Metropolis Healthcare
- November 5, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Inox India, Shivalik Bimetal and Metropolis Healthcare: ROE of 12.6% to 23.1% and FY22 to FY26 revenue CAGR of 7.6% to 19.4%. Prices as of 4 Nov 2026.
Quick Answer
The three cryogenic tank, bimetal strip and lab stocks to watch are Inox India, Shivalik Bimetal and Metropolis Healthcare. Their return on equity ranges from 12.6% to 23.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 19.4%. Inox India leads on both return on equity at 23.1% and revenue growth at 19.4% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.
Cryogenic tank, bimetal strip and lab stocks let investors follow companies that serve a growing part of the Indian economy. Inox India, Shivalik Bimetal and Metropolis Healthcare cover a cryogenic tanks maker, a bimetal strips maker and a diagnostics company.
This list covers three cryogenic tank, bimetal strip and lab stocks with complete current figures: Inox India, Shivalik Bimetal and Metropolis Healthcare. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Cryogenic Tank, Bimetal Strip and Lab Stocks?
Cryogenic tank, bimetal strip and lab stocks are listed companies that make cryogenic tanks to store and move industrial gases, produce bimetal strips and electrical contacts, and run pathology labs and collection centres. Their earnings depend on industrial gas projects, appliance and vehicle output and test volumes.
Cryogenic Tank, Bimetal Strip and Lab Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Inox India | 1,936.7 | 18,179 | 71.3 | 22.4 | 23.1 | 0.07 |
| Shivalik Bimetal | 1,071.3 | 5,383 | 50.7 | 11.3 | 19.9 | 0.13 |
| Metropolis Healthcare | 581.25 | 10,780 | 53.1 | 59.6 | 12.6 | 0.15 |
On valuation, Metropolis Healthcare trades at a P/E below the industry P/E, while Inox India and Shivalik Bimetal trade above it, which reflects the growth the market already expects. Readers comparing cryogenic tank, bimetal strip and lab stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in cryogenic tank, bimetal strip and lab stocks can use the coming numbers to test whether growth is holding.
Why Do Cryogenic Tank, Bimetal Strip and Lab Stocks Have a Strong Roadmap in India?
Cryogenic tank, bimetal strip and lab stocks have a strong roadmap in India because growing industrial gas use, rising appliance output and wider health testing keep widening the market for these companies.
- Cryogenic tanks. Steel, health and energy users need gas storage.
- Bimetal strips. Appliances use thermal controls.
- Diagnostics. More people take regular tests.
Why Inox India Features Among These Cryogenic Tank, Bimetal Strip and Lab Stocks
Among the cryogenic tank, bimetal strip and lab stocks on this list, Inox India, based in Vadodara, is a leading maker of cryogenic tanks and systems used to store and transport industrial gases, LNG and other liquefied gases.
In the June 2026 quarter, revenue grew 8.3% year on year to Rs 382 crore. Revenue rose from Rs 804 crore in FY22 to Rs 1,632 crore in FY26, a compound annual growth rate of 19.4%.
Net profit grew from Rs 130 crore in FY22 to Rs 258 crore in FY26, which works out to a compound annual growth rate of 18.6%. The company has a return on equity of 23.1%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 18,179 crore. The stock trades at a P/E of 71.3, above the industry P/E of 22.4.
Roadmap: Demand for industrial gases, LNG infrastructure, hydrogen and space-related applications supports its order flow. Its equipment is built for long service life, and a large share of sales comes from exports, which provides geographic spread.
What to watch: Monitor order inflow from LNG and industrial gas customers, as large orders can shape quarterly numbers.
Why Shivalik Bimetal Features Among These Cryogenic Tank, Bimetal Strip and Lab Stocks
Among the industrial gas, electrical and health shares on this list, Shivalik Bimetal Controls makes thermostatic bimetal strips, shunts and electrical contact components used in appliances, automobiles and electrical equipment, selling to customers in India and abroad.
The company has a return on equity of 19.9%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 5,383 crore. The stock trades at a P/E of 50.7, above the industry P/E of 11.3.
Revenue rose from Rs 329 crore in FY22 to Rs 583 crore in FY26, a compound annual growth rate of 15.3%. Net profit grew from Rs 55.1 crore in FY22 to Rs 95.9 crore in FY26, which works out to a compound annual growth rate of 14.8%. In the June 2026 quarter, revenue grew 33.7% year on year to Rs 186 crore, while net profit rose 44.9% to Rs 33.0 crore.
Roadmap: The company is growing its shunt business for electric and hybrid vehicles and smart meters while adding new components for industrial and appliance customers. Its materials expertise supports a strong position in the niche.
What to watch: Follow shunt demand from electric vehicles and meters and new component launches.
Why Metropolis Healthcare Features Among These Cryogenic Tank, Bimetal Strip and Lab Stocks
Among the three companies on this list, Metropolis Healthcare, headquartered in Mumbai, is a pathology and diagnostics company that runs a national network of laboratories, patient service centres and collection points, and also serves hospitals and corporate clients.
Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%.
In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P/E of 53.1, below the industry P/E of 59.6.
Roadmap: The company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.
What to watch: Follow test volumes per patient and the pace at which newer regions turn profitable.
Inox India vs Shivalik Bimetal vs Metropolis Healthcare on Key Financials
The table below sets the three cryogenic tank, bimetal strip and lab stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Inox India | 804 | 1,632 | 19.4% | 258 | 15.8% |
| Shivalik Bimetal | 329 | 583 | 15.3% | 95.9 | 16.4% |
| Metropolis Healthcare | 1,246 | 1,671 | 7.6% | 191 | 11.4% |
Inox India posts the highest return on equity in this group at 23.1%. Metropolis Healthcare has the largest FY26 revenue at Rs 1,671 crore, and Inox India shows the fastest revenue growth with a 19.4% compound annual rate. A useful habit with cryogenic tank, bimetal strip and lab stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several liquid gas tank, thermal control and pathology stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Inox India | 352 | 382 | 8.3% |
| Shivalik Bimetal | 139 | 186 | 33.7% |
| Metropolis Healthcare | 394 | 455 | 15.7% |
Key Risks to Check Before Investing in Cryogenic Tank, Bimetal Strip and Lab Stocks
Every theme carries risks that deserve a check before any decision. For these cryogenic tank, bimetal strip and lab stocks, the main points are: Long-term industrial gas, electrical and health shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Order timing. Project awards can shift between periods.
- Test volumes. Footfall and test mix can vary with seasons.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter cryogenic tank, bimetal strip and lab stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Cryogenic Tank, Bimetal Strip and Lab Stocks
Cryogenic tank, bimetal strip and lab stocks reward investors who follow demand trends, order books and margins together. Inox India, Shivalik Bimetal and Metropolis Healthcare each have a clear plan to grow. Based on the 4 November 2026 close, Inox India trades at Rs 1,936.7, Shivalik Bimetal at Rs 1,071.3 and Metropolis Healthcare at Rs 581.25. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these cryogenic tank, bimetal strip and lab stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track cryogenic tank, bimetal strip and lab stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are cryogenic tank, bimetal strip and lab stocks?
Ans. Cryogenic tank, bimetal strip and lab stocks are listed companies that make cryogenic tanks to store and move industrial gases, produce bimetal strips and electrical contacts, and run pathology labs and collection centres. Their earnings depend on industrial gas projects, appliance and vehicle output and test volumes. This list looks at three of them, Inox India, Shivalik Bimetal and Metropolis Healthcare, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.
Which cryogenic tank, bimetal strip and lab stocks are covered in this list?
Ans. This list covers Inox India, Shivalik Bimetal and Metropolis Healthcare. Based on the 4 November 2026 close, Inox India traded at Rs 1,936.7, Shivalik Bimetal at Rs 1,071.3 and Metropolis Healthcare at Rs 581.25. Their return on equity ranges from 12.6% to 23.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 19.4%.
Why do cryogenic tank, bimetal strip and lab stocks have a strong future roadmap in India?
Ans. Cryogenic tank, bimetal strip and lab stocks have a strong roadmap in India because growing industrial gas use, rising appliance output and wider health testing keep widening the market for these companies. The main drivers are as follows. Cryogenic tanks. Steel, health and energy users need gas storage. Bimetal strips. Appliances use thermal controls. Diagnostics. More people take regular tests. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Inox India performed financially?
Ans. Revenue rose from Rs 804 crore in FY22 to Rs 1,632 crore in FY26, a compound annual growth rate of 19.4%. Net profit grew from Rs 130 crore in FY22 to Rs 258 crore in FY26, which works out to a compound annual growth rate of 18.6%. In the June 2026 quarter, revenue grew 8.3% year on year to Rs 382 crore. The company has a return on equity of 23.1%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 18,179 crore. The stock trades at a P/E of 71.3, above the industry P/E of 22.4. Looking ahead, demand for industrial gases, LNG infrastructure, hydrogen and space-related applications supports its order flow. Its equipment is built for long service life, and a large share of sales comes from exports, which provides geographic spread.
How has Shivalik Bimetal performed financially?
Ans. Revenue rose from Rs 329 crore in FY22 to Rs 583 crore in FY26, a compound annual growth rate of 15.3%. Net profit grew from Rs 55.1 crore in FY22 to Rs 95.9 crore in FY26, which works out to a compound annual growth rate of 14.8%. In the June 2026 quarter, revenue grew 33.7% year on year to Rs 186 crore, while net profit rose 44.9% to Rs 33.0 crore. The company has a return on equity of 19.9%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 5,383 crore. The stock trades at a P/E of 50.7, above the industry P/E of 11.3. Looking ahead, the company is growing its shunt business for electric and hybrid vehicles and smart meters while adding new components for industrial and appliance customers. Its materials expertise supports a strong position in the niche.
How has Metropolis Healthcare performed financially?
Ans. Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%. In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P/E of 53.1, below the industry P/E of 59.6. Looking ahead, the company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.
What risks should investors check before buying cryogenic tank, bimetal strip and lab stocks?
Ans. Investors should check a few risks before buying cryogenic tank, bimetal strip and lab stocks. Order timing. Project awards can shift between periods. Test volumes. Footfall and test mix can vary with seasons. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of cryogenic tank, bimetal strip and lab stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.